Argent BioPharma Limited revenue for the last year amounted to 2.26 M USD, the most of which — 1.67 M USD — came from its highest performing source at the moment, Cannabinoids, the year earlier bringing 2.78 M USD. The greatest contribution to the revenue figure was made by Slovenia — last year it brought Argent BioPharma Limited 1.90 M USD, and the year before that — 2.22 M USD.